Post

Life science SMEs “heading out of the funding winter”

After what has been deemed a “funding winter” for life science SMEs, building a strong data package to attract larger …

Biogen reports net income of $393.4m in Q1 2024

Biogen has reported net income of $393.4m for the first quarter (Q1) of 2024, an increase from $387.6m in the …

US FDA approves Utility Therapeutics’ Pivya tablets for UTIs

The US Food and Drug Administration (FDA) has approved Utility Therapeutics’ Pivya tablets, a new treatment for female adults with …

Investors anticipate “bounce-back” in European private investment

The Swiss biotech ecosystem suffers from a “weak public market”, said Francesco de Rubertis, a cofounder at Medicxi Ventures. Despite …

Novartis bags paediatric FDA label expansion for Lutathera

Novartis has received a US Food and Drug Administration (FDA) approval for the label expansion of its peptide receptor radionuclide …